In this model, researchers administered high-dose tamoxifen to induce parietal cell atrophy and spasmolytic polypeptide-expressing metaplasia (SPEM) and found that IL-27-deficient mice developed more severe gastritis, atrophy and SPEM compared to control mice. This evidence concerns the gene IL27 and gastritis.